Timour Baslan
0000-0001-5674-6432
Publication & Citation Trends
Publications
0 total
Abstract PR013: Dynamic kinome reprogramming and metabolic rewiring drive adaptive resistance to RAS inhibition in pancreatic cancer
Cited by 0
Semantic Scholar
SMAD4 induces opposite effects on metastatic growth from pancreatic tumors depending on the organ of residence
Cited by 4
Semantic Scholar
Abstract LB288: Determination of the MYC- and TEAD-dependent transcriptome in pancreatic cancer
Cited by 1
Semantic Scholar
Sparse whole genome sequencing and machine learning of AML genomes reveals novel, clinically relevant genetics.
Cited by 0
Semantic Scholar
Abstract B093: Investigating mechanisms of PARP inhibitor resistance in homologous recombination deficient PDAC using patient-derived organoid models
Cited by 0
Semantic Scholar
α-Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemia
Cited by 13
Semantic Scholar
Abstract 1927: Resistance to RAS-GTP inhibition in models of pancreatic ductal adenocarcinoma arises downstream of RAS effectors
Cited by 0
Semantic Scholar
Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer
Cited by 143
Semantic Scholar
Mutant IDH uncouples p53 from target gene regulation to disable tumor suppression OA
Cited by 0
Semantic Scholar
Metastatic site influences driver gene function in pancreatic cancer OA
Cited by 2
Semantic Scholar
Research Topics
Cancer Genomics and Diagnostics
(47)
Epigenetics and DNA Methylation
(34)
Pancreatic and Hepatic Oncology Research
(20)
BRCA gene mutations in cancer
(18)
Acute Myeloid Leukemia Research
(16)
Affiliations
University of the Sciences
Memorial Sloan Kettering Cancer Center
Children's Hospital of Philadelphia
Howard Hughes Medical Institute
Cornell University